FUSE-AI develops medical AI software. Our AI products analyze MRI images and support radiologists in diagnosing cancer. The intelligent software can be integrated into existing diagnostic software systems via interfaces. In our product development, we use modern deep learning methods, which form the core of AI-supported medical image analysis. Our AI software analyzes MRI images of the prostate. It supports radiologists in detecting lesions and thus in diagnosing prostate cancer. The advantages: • Automated process • Time savings • Cost reduction per patient • Faster provision of information to patients • Radiologists can learn from the expertise of other radiologists Increased effectiveness: • Time and cost savings, as radiologists automatically receive an annotation of the prostate that they can correct or confirm. • As a result, more patients can use the MRI per unit of time. Conclusion: We offer radiologists a tool for faster and more targeted annotation of the prostate. The AI-based software can support radiologists in making faster and more targeted diagnoses. The AI software is expected to be launched in the second quarter of 2022. Additional services: We are a broadly positioned contractor for companies in the medical, medical technology, and pharmaceutical sectors. Schedule a free workshop with us! We develop and certify medical apps. We support companies in health marketing. We specialize in regulatory affairs. We evaluate corporate data using data science. We develop AI-based pose and facial recognition. We use blockchain in the healthcare sector. We offer support in bioinformatics. We are a research partner.